SYPLF yields 0.02% · PFE yields 6.13%● Live data
📍 PFE pulled ahead of the other in Year 8
Combined, SYPLF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of SYPLF + PFE for your $10,000?
Sanyo Special Steel Co., Ltd., together with its subsidiaries, manufactures and sells special steel products in Japan and internationally. The company operates through Steel Materials, Powder Business, Shape Material Business, and Others segments. The Steel Materials segment manufactures and sells various special steel products, such as bearing steel, machine structural steel, stainless steel, heat resistant steel, and tool steel. The Powder Business segment manufactures and sells metal powder products. The Shape Material Business manufactures and sells raw material products made from special steel bars and pipes. The Others segment provides information processing services for the steel materials, powder, and raw material businesses. The company's steel products are used in a range of automobiles, railways, construction machinery, electronics products, and information and communication equipment. The company was formerly known as Sanyo Steel Works and changed its name to Sanyo Special Steel Co., Ltd. in 1959. The company was founded in 1933 and is headquartered in Himeji, Japan. Sanyo Special Steel Co., Ltd. operates as a subsidiary of Nippon Steel Corporation.
Full SYPLF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.